about
Inside the Envelope: Endogenous Retrovirus-K Env as a Biomarker and Therapeutic TargetAntiviral activity of animal venom peptides and related compoundsPrimate TRIM5 proteins form hexagonal nets on HIV-1 capsids.Non-degradative Ubiquitination of Protein Kinases.HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in InfectionSLFN11 inhibits checkpoint maintenance and homologous recombination repair.Influence of Glycosylation Inhibition on the Binding of KIR3DL1 to HLA-B*57:01.HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3.Sex differences in HIV-1-mediated immunopathology.NLRX1 Sequesters STING to Negatively Regulate the Interferon Response, Thereby Facilitating the Replication of HIV-1 and DNA Viruses.Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairsNatural Killer Cell Diversity in Viral Infection: Why and How Much?TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes.Immunity to Avian Leukosis Virus: Where Are We Now and What Should We Do?Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitnessExosomes contribute to the transmission of anti-HIV activity from TLR3-activated brain microvascular endothelial cells to macrophages.Interplay between HIV-1 and Toll-like receptors in human myeloid cells: friend or foe in HIV-1 pathogenesis?Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV.Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV InfectionExperimental systems for studying Plasmodium/HIV coinfection.Interactions of porcine circovirus 2 with its hosts.Preclinical Mouse Models for Analysis of the Therapeutic Potential of Engineered Oncolytic Herpes VirusesA penalized regression approach to haplotype reconstruction of viral populations arising in early HIV/SIV infection.Current views on interferon therapy for HIV.Impact of maternal HIV-1 infection on the feto-maternal crosstalk and consequences for pregnancy outcome and infant health.Infectious immunity in the central nervous system and brain function.Dopaminergic Regulation of Innate Immunity: a Review.Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.Vaccine-modified NF-kB and GR signaling in cervicovaginal epithelium correlates with protection.The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles.[Plasmacytoid dendritic cells: the novel Eldorado for antiviral therapy?].Reading the fine print: sequence-specific activation of cGAS.Human Immunodeficiency Virus 1 and Type I Interferons-Where Sex Makes a DifferenceNatural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection.Myeloid Cell Interaction with HIV: A Complex Relationship.Are Evolution and the Intracellular Innate Immune System Key Determinants in HIV Transmission?Deep sequencing of HIV-1 reverse transcripts reveals the multifaceted antiviral functions of APOBEC3G.The Antiviral Immune Response and Its Impact on the HIV-1 Reservoir.Crude Ecklonia cava Flake Extracts Attenuate Inflammation through the Regulation of TLR4 Signaling Pathway in LPS-Induced RAW264.7 Cells.Porcine MKRN1 modulates the replication and pathogenesis of PCV2 by inducing capsid protein ubiquitination and degradation.
P2860
Q26776132-D5749438-A7C6-42A8-ACD0-C09131343AC6Q28353903-B16F61E2-7D7C-4AF7-A5C1-44CD4AF53FEFQ30276687-BD5CA88F-B56B-43CE-A2BB-8F0BC2B626ACQ30388842-B89D5790-9B69-4CDB-9005-7500015B149BQ33629133-C141F942-EBE7-4581-9244-93E96FDA8ACAQ35866775-E76E3E1C-855E-42FA-A219-2AD046E0E886Q35872389-0BC8C079-1FB0-4543-BABA-CC06D7958D45Q36080904-38B046A4-1584-4EF2-9959-7BEB446B42A2Q36764788-26930810-99A7-4104-951C-07A4CB6D828BQ36801960-16BA3AEF-2626-4777-9E87-2C583853A399Q37233074-E49A304E-5C25-4482-AABF-A90BC5A6612BQ37252674-9F9D2062-B8E6-4ACB-A8B8-2E9CA68DD292Q37460727-CD97AA25-2C8F-4BDD-BE73-409E2A8606B0Q37521273-BA06FEF4-B447-4DCD-B539-C1FB59ADBBB9Q37612507-E743E013-5C01-4438-8B5A-9645335DC361Q37643710-BA68BB6E-7582-48BD-9F43-8D6BD8B13679Q38573911-6DE1C749-BE99-4019-A352-B3C6FEAD2DD4Q38685785-B765FA47-B01F-4DBF-9FE9-454759C9839CQ38749963-99B921FC-85C2-464F-94B9-13713D51BD0DQ38786988-96CC94A2-CFD7-41E3-BFC7-0F75191A736DQ38789402-B0622EEF-DB97-426F-8817-75CF6506C476Q38795324-3531BD5C-73B0-41E5-9BD2-801CD0263BBAQ38853281-6A7D4200-522E-4D6E-8D6D-09F18D73AD55Q38860634-F979A7D7-2523-437A-9641-F61237F8EC9DQ38890564-6CFDA545-E174-45E9-8D65-83855CEE531AQ39090558-94B74A4C-96CD-4175-98BB-E63AB9DB6396Q39348712-DA4C01B5-3267-48EB-813D-56DF2526162CQ40077472-C5CA18EC-AA0A-442A-A375-E6D518E673F0Q40089493-428CFAF6-B3E8-4E36-A6BD-1A9213FC1ECDQ40142057-B7681FF6-E4DD-490A-A6B3-71175CFA1BF3Q40932064-B3D2BFF2-F83B-47F6-82C4-BE53176D541CQ42121451-99B6DCC2-205D-4E1F-BD71-3D5B43BF27BAQ42369099-1282E44A-F377-40CC-BAE1-84E8DC393667Q46722989-BDD50404-6E65-4957-8615-1A66068970D8Q47141408-F8E5EAED-E4B4-4CAA-B256-CA3CE91B8012Q47146547-3D9E9D5D-04B9-42C6-87C6-7080D6EC509EQ47380909-B3A40B62-F2A1-468E-870A-C8FE263B891BQ47600020-C2EA0A10-3265-4EFC-98F5-4C1FE39F0D5EQ52654907-B460F796-980A-41CB-8A1C-273F124C7EDAQ52668677-AFD5D073-A412-4AF4-B160-1421AFAE6C61
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Innate immunity against HIV-1 infection.
@en
type
label
Innate immunity against HIV-1 infection.
@en
prefLabel
Innate immunity against HIV-1 infection.
@en
P2860
P356
P1433
P1476
Innate immunity against HIV-1 infection.
@en
P2860
P304
P356
10.1038/NI.3157
P407
P577
2015-06-01T00:00:00Z